Cardiovascular, renal and metabolic diseases are inextricably linked and are the leading causes of mortality and morbidity in the United States, especially in Mississippi which has the highest prevalence in the nation of these diseases. These disorders usually cluster together and are highly interdependent. Obesity and associated metabolic disorders, such as diabetes, are major causes of cardiovascular and renal disease. Abnormal kidney function is an important cause as well as a consequence of hypertension, a key risk factor for cardiovascular diseases such coronary artery disease and stroke. Understanding the complex relationships among cardiovascular, renal, and metabolic disorders and developing new therapeutic approaches requires a paradigm shift in research that incorporates multidisciplinary integrated approaches, combining the efforts of basic, clinical and population scientists. A major objective of this proposal is to develop an internationally recognized Cardiorenal and Metabolic Diseases Research Center (CMDRC) that brings together a multidisciplinary group of basic, clinical and population scientists working on a common synergistic theme, and to facilitate their collaborations.
The specific aims are: 1) To develop infrastructure and core facilities that foster excellence in basic, clinical, and population research in cardiorenal and metabolic diseases and increase competitiveness of junior investigators for independent funding from NIH and other national biomedical research programs.;2) To develop mentoring and education programs and research support for promising junior investigators so that they can become productive, independent investigators who can successfully compete for NIH funding;3) To achieve the specific aims of the research projects described by the junior investigators in this proposal, and to foster their career development;4) To develop a pipeline of diverse predoctoral graduate students, medical students and postdoctoral fellows trained in cutting edge cardiorenal and metabolic diseases research so they become the next generation of researchers in this field;major emphasis will be placed on recruiting and mentoring underrepresented minority investigators through partnerships with local minority institutions;5) To enhance collaborations and interactions among established investigators from multiple disciplines in cardiorenal and metabolic diseases at UMMC, as well as with external partners;6) To strengthen cardiorenal and metabolic disease research at UMMC by recruiting new faculty with expertise in clinical and translational research and in emerging technologies, such as in vivo imaging, molecular genetics, bioinformatics, and systems analysis.

Public Health Relevance

Cardiorenal and metabolic diseases are the leading causes of mortality and morbidity in the United States, especially in Mississippi which has the highest prevalence in the nation of these diseases. This is a critical area for research development in Mississippi, especially in view of th emerging opportunities to develop a comprehensive, multidisciplinary research center at UMMC that focuses on these major causes of mortality and morbidity. This proposal represents a plan to develop a unique, internationally recognized COBRE that is dedicated to improving lives through research, discovery and innovation.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Exploratory Grants (P20)
Project #
1P20GM104357-01
Application #
8432513
Study Section
Special Emphasis Panel (ZGM1-TWD-B (CB))
Program Officer
Liu, Yanping
Project Start
2013-09-05
Project End
2018-04-30
Budget Start
2013-09-05
Budget End
2014-04-30
Support Year
1
Fiscal Year
2013
Total Cost
$2,278,362
Indirect Cost
$778,849
Name
University of Mississippi Medical Center
Department
Physiology
Type
Schools of Medicine
DUNS #
928824473
City
Jackson
State
MS
Country
United States
Zip Code
39216
Altara, Raffaele; Harmancey, Romain; Didion, Sean P et al. (2016) Cardiac STAT3 Deficiency Impairs Contractility and Metabolic Homeostasis in Hypertension. Front Pharmacol 7:436
Lawson, William J; Shirey, Kristin; Spann, Redin A et al. (2016) Vertical sleeve gastrectomy improves indices of metabolic disease in rodent model of surgical menopause. Menopause :
Lindsey, Merry L; Hall, Michael E; Harmancey, Romain et al. (2016) Adapting extracellular matrix proteomics for clinical studies on cardiac remodeling post-myocardial infarction. Clin Proteomics 13:19
Ma, Yonggang (2016) LRP5: A novel anti-inflammatory macrophage marker that positively regulates migration and phagocytosis. J Mol Cell Cardiol 91:61-2
Dasinger, John Henry; Alexander, Barbara T (2016) Gender differences in developmental programming of cardiovascular diseases. Clin Sci (Lond) 130:337-48
Yabluchanskiy, Andriy; Ma, Yonggang; DeLeon-Pennell, Kristine Y et al. (2016) Myocardial Infarction Superimposed on Aging: MMP-9 Deletion Promotes M2 Macrophage Polarization. J Gerontol A Biol Sci Med Sci 71:475-83
Roman, Richard J; Fan, Fan; Zhuo, Jia L (2016) Intrarenal Renin-Angiotensin System: Locally Synthesized or Taken up Via Endocytosis? Hypertension 67:831-3
Evaristi, Maria Francesca; Caubère, Céline; Harmancey, Romain et al. (2016) Increased mean aliphatic lipid chain length in left ventricular hypertrophy secondary to arterial hypertension: A cross-sectional study. Medicine (Baltimore) 95:e4965
Padmanabhan Iyer, Rugmani; Chiao, Ying Ann; Flynn, Elizabeth R et al. (2016) Matrix metalloproteinase-9-dependent mechanisms of reduced contractility and increased stiffness in the aging heart. Proteomics Clin Appl 10:92-107
Iyer, Rugmani Padmanabhan; Jung, Mira; Lindsey, Merry L (2016) MMP-9 signaling in the left ventricle following myocardial infarction. Am J Physiol Heart Circ Physiol 311:H190-8

Showing the most recent 10 out of 125 publications